Member Exclusive

Company receives funding for next-generation drug discovery platform that uses artificial intelligence technology

Investment will enable company to scale-up its platform to screen more targets and diseases than they were previously capable of

Go to the profile of Hannah Coaker
Oct 06, 2016

Please sign in or register for FREE

Register to MedChemNet

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.